LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is a serious metabolic disorder characterized by excess fat accumulation in the liver. Over the past decade, NAFLD prevalence and incidence have risen globally. There are currently no effective licensed drugs for its treatment. Thus, further study is required...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jibeom, Kim, Hyeonhui, Kang, Yun-Won, Kim, Yumin, Park, Moon-young, Song, Ji-Hong, Jo, Yunju, Dao, Tam, Ryu, Dongryeol, Lee, Junguee, Oh, Chang-Myung, Park, Sangkyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394021/
https://www.ncbi.nlm.nih.gov/pubmed/37394588
http://dx.doi.org/10.1038/s12276-023-01033-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394021/
https://www.ncbi.nlm.nih.gov/pubmed/37394588
http://dx.doi.org/10.1038/s12276-023-01033-w

Ejemplares similares